Literature DB >> 19150304

The coagulation cascade in cirrhosis.

Dougald M Monroe1, Maureane Hoffman2.   

Abstract

The coagulation "cascade" model accurately represents the mechanisms of the prothrombin time and activated partial thromboplastin time tests. However, these tests and the "cascade" model do not accurately reflect the risk of hemorrhage or thrombosis in vivo. In hepatic insufficiency, a balanced reduction in the levels of most of pro- and anticoagulant proteins produced in the liver does not impair thrombin generation until levels are quite low. However, the ability of the coagulation system to tolerate or recover from an insult is markedly impaired in liver disease. This allows the coagulation system to be more easily tipped into a state favoring either hemorrhage or thrombosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19150304     DOI: 10.1016/j.cld.2008.09.014

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  15 in total

Review 1.  Mechanisms and cell signaling in alcoholic liver disease.

Authors:  Juliane I Beier; Craig J McClain
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

Review 2.  Portal vein thrombosis in cirrhosis: Controversies and latest developments.

Authors:  Damian J Harding; M Thamara P R Perera; Frederick Chen; Simon Olliff; Dhiraj Tripathi
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

3.  Hepatobiliary quiz (answers)-13 (2015).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2015-03-21

Review 4.  Portal vein thrombosis in liver cirrhosis.

Authors:  Nao Kinjo; Hirofumi Kawanaka; Tomohiko Akahoshi; Yoshihiro Matsumoto; Masahiro Kamori; Yoshihiro Nagao; Naotaka Hashimoto; Hideo Uehara; Morimasa Tomikawa; Ken Shirabe; Yoshihiko Maehara
Journal:  World J Hepatol       Date:  2014-02-27

Review 5.  Portal vein thrombosis in cirrhosis.

Authors:  Kaiser Raja; Mathew Jacob; Sonal Asthana
Journal:  J Clin Exp Hepatol       Date:  2013-12-31

6.  Forns Index is a predictor of cardiopulmonary bypass time and outcomes in Fontan conversion.

Authors:  Gaku Izumi; Atsuhito Takeda; Hirokuni Yamazawa; Osamu Sasaki; Nobuyasu Kato; Hidetsugu Asai; Tsuyoshi Tachibana; Yoshiro Matsui
Journal:  Heart Vessels       Date:  2019-09-27       Impact factor: 2.037

7.  The Association Between Bronchoscopy and the Prognoses of Patients With Ventilator-Associated Pneumonia in Intensive Care Units: A Retrospective Study Based on the MIMIC-IV Database.

Authors:  Luming Zhang; Shaojin Li; Shiqi Yuan; Xuehao Lu; Jieyao Li; Yu Liu; Tao Huang; Jun Lyu; Haiyan Yin
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

8.  Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers.

Authors:  Lydia Giannitrapani; Walter Granà; Anna Licata; Cosima Schiavone; Giuseppe Montalto; Maurizio Soresi
Journal:  Med Princ Pract       Date:  2018-08-14       Impact factor: 1.927

9.  Viral cirrhosis: an overview of haemostatic alterations and clinical consequences.

Authors:  Francesca Romana Ponziani; Valerio De Stefano; Antonio Gasbarrini
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-30       Impact factor: 2.576

Review 10.  Etiology and Complications of Portal Vein Thrombosis.

Authors:  Jonel Trebicka; Christian P Strassburg
Journal:  Viszeralmedizin       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.